Logo

American Heart Association

  33
  0


Final ID:

Precision therapy for Genetic HCM: Cardiac Myosin Inhibitors

  • Kawana, Masataka  ( STANFORD UNIVERSITY , Stanford , California , United States )
  • Wilsbacher, Lisa  ( NORTHWESTERN UNIVERSITY , Evanston, IL , Illinois , United States )
  • Wheeler, Matthew  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
  • Author Disclosures:
    Masataka Kawana: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now) ; Research Funding (PI or named investigator):FANCL Corp.:Active (exists now) ; Advisor:Holosis Health:Active (exists now) ; Advisor:Cardiac RSK3 Inhibitors, LLC:Active (exists now) | Lisa Wilsbacher: DO NOT have relevant financial relationships | Matthew Wheeler: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

What A Busy Cardiologist Needs to Know About Genetics

Friday, 11/07/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Pharmacogenomics - where does it help me?

Luzum Jasmine, Wells Quinn, Pereira Naveen

A positive genetic test in sudden cardiac death: What do I tell the family?

Ezekian Jordan, Perez Marco, Ingles Jodie

More abstracts from these authors:
Discussant: MUSIC-HFpEF

Kawana Masataka

Wrap -Up

Chahal Choudhary Anwar A., Wilsbacher Lisa

You have to be authorized to contact abstract author. Please, Login
Not Available